Life Sciences Greenhouse of Central Pennsylvania

A Venture Capital Investment Company for Life Sciences Enterprises in Central Pennsylvania

  • Home
  • About Us
    • About LSGPA
    • Our Team
    • Board of Directors
  • The Funding Process
  • Resources
    • The Ecosystem
    • Applicant Support
    • Why Central PA?
  • Portfolio Companies
    • Portfolio Overview
    • Devices and Diagnostics
    • Drug Discovery
    • Other
  • News and Events
    • Press Releasees
    • Video Gallery
  • Apply Now
  • Contact Us

Archives for July 2020

Saladax Biomedical launches clozapine test in the US after FDA grants market authorization

July 13, 2020 By Admin

Saladax is advancing personalized medicine by providing psychiatrists with the first commercially available antipsychotic test in the U.S.July 08, 2020 02:00 PM Eastern Daylight Time

BETHLEHEM, Pa.–(BUSINESS WIRE)–Saladax Biomedical Inc., announced that the FDA has granted their De Novo Request for a rapid blood test that measures clozapine levels in psychiatric patients. This is a milestone in psychiatry as the MyCare™ Psychiatry Clozapine Assay Kit is the only commercial test available in the US for monitoring clozapine levels.

Saladax Biomedical launches clozapine test in the US after FDA grants market authorizationTweet this

“We are excited to receive FDA Clearance of our clozapine assay. We developed the MyCare Psychiatry line based on extensive research into psychiatrists’ needs. The result is a game-changing test that delivers clinicians access to rapid quantitative blood levels of the psychotherapeutic drugs their patients are on,” said Dr. Salvatore J. Salamone, Founder/CEO. “The MyCare Psychiatry Clozapine Assay Kit is the first of the MyCare line and delivers a fast and accurate result giving physicians timely information of high medical value. When used in conjunction with other laboratory and clinical information, this test can aid in the management of individuals prescribed clozapine for treatment resistant schizophrenia.”

The market authorization of the clozapine assay comes at an excellent time with the recent publication of the US consensus guidelines by the American Society of Clinical Psychopharmacology. These guidelines underscore the importance of monitoring antipsychotic levels and provide guidance on how to implement testing in everyday practice.

It is estimated that schizophrenia affects approximately 3.5 million Americans, of which 25-30% meet the criteria for treatment resistant schizophrenia (TRS). TRS patients are those that are suffering with schizophrenia and are non-responsive to, or intolerant of, conventional antipsychotic medications. For these patients, the only treatment approved and recommended by the American Psychiatric Association guidelines is clozapine. Other countries prescribe clozapine as much as eight times more than in the US and underutilization of clozapine is a concern to clinicians. The availability of a fast and effective tool, like the Saladax Test, could be an important tool to improve the utilization of clozapine.

Clozapine is the first test in the MyCare Psychiatry line available in the US. The line includes tests for quetiapine, aripiprazole, risperidone, olanzapine and paliperidone. The test takes less than ten minutes to run and can positively impact the management of mental health patients.

ABOUT SALADAX

Founded in 2004, Saladax Biomedical, Inc. is a privately held company headquartered at Ben Franklin TechVentures® located in Bethlehem, PA.

Saladax develops rapid blood tests for point of care and for laboratory analysers for use in psychiatry and oncology. The Saladax MyCare Psychiatry line provides drug level tests of the most commonly prescribed antipsychotics. Saladax believes that truly personalized medicine can only exist when the right drug is taken at the right dose. Our diagnostic reagent kits are distributed worldwide and are under development for use in the United States. Saladax is ISO 13485:2016 certified.

Filed Under: News and Events

Latest News

Gov. Wolf Announces $268 Million in New ARPA Funding to Boost Small Business Success, Job Creation Opportunities Across Pennsylvania

Governor Tom Wolf announced that Pennsylvania has been awarded nearly $268 million in American Rescue Plan funding, through the State Small Business … Read More...

Saladax Biomedical Expanding Access to Antipsychotic Drug Testing With Beckman Coulter Partnership

Apr 11, 2022 | Kelsy Ketchum NEW YORK – Measuring the presence of antipsychotic drugs in a patient's system is currently a time-consuming and … Read More...

THE LIFE SCIENCES GREENHOUSE OF CENTRAL PA ANNOUNCES CHANGE IN LEADERSHIP

President and CEO Mel Billingsley, PhD, Retiring after 20 Years at Helm Harrisburg, PA  ̶  March 24, 2022.  The Life Sciences … Read More...

Saladax Biomedical and HLS Therapeutics Strengthen Partnership With an Exclusive Distribution Agreement for Canada

BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc (Saladax) is pleased to announce an exclusive distribution agreement with HLS Therapeutics … Read More...

Immunomic Therapeutics Announces Collaboration With iOncologi

ROCKVILLE, Md.–(BUSINESS WIRE)–Immunomic Therapeutics, Inc., (“ITI”) a privately held clinical-stage biotechnology company focused on advancing its … Read More...

Archives

  • July 2022
  • April 2022
  • December 2021
  • August 2021
  • July 2021
  • April 2021
  • March 2021
  • January 2021
  • November 2020
  • July 2020
  • April 2020
  • January 2020
  • September 2019
  • August 2019
  • May 2019
  • March 2019
  • February 2019
  • January 2019
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • July 2017
  • June 2017
  • March 2017
  • January 2017
  • October 2016
  • September 2016
  • August 2016
  • June 2016
  • May 2016
  • January 2016

LSGPA
Life Sciences Greenhouse of Central Pennsylvania
225 Market Street
Suite 500
Harrisburg, PA  17101
1-717-635-2100

Strawberries
LSGPA Copyright © 2018

Copyright © 2022 · WordPress · Log in